MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$47,872K
Short-term investments
$41,106K
Prepaid expenses and
other current assets
$6,136K
Inventories
$3,743K
Accounts receivable, net
$216K
Total current assets
$99,073K
Long-term investments
$20,160K
Other assets
$361K
Accumulated deficit
-$1,706,047K
Accumulated other
comprehensive loss
-$2,182K
Total assets
$119,594K
Total stockholders'
deficit attributable to...
-$30,038K
Additional paid-in capital
$1,677,179K
Common stock, 0.01 par
value 225,000 shares...
$1,012K
Total liabilities,
redeemable...
$119,594K
Total deficit
-$17,005K
Nonredeemable
non-controlling interests
$13,033K
Total liabilities
$115,119K
Redeemable
non-controlling interests
$21,480K
Liability related to sale
of future...
$65,980K
Total current
liabilities
$29,242K
Product development
obligations
$19,560K
Deferred revenue, net of
current
$255K
Other long-term
liabilities
$82K
Accrued and other
current liabilities
$20,183K
Deferred revenue
$5,314K
Accounts payable
$3,745K
Back
Back
Balance Sheet
source: myfinsight.com
KYNTRA BIO, INC. (KYNB)
KYNTRA BIO, INC. (KYNB)